Pharmaceutics (Apr 2022)

Squalene-Based Nano-Assemblies Improve the Pro-Autophagic Activity of Trehalose

  • Giulia Frapporti,
  • Eleonora Colombo,
  • Hazem Ahmed,
  • Giulia Assoni,
  • Laura Polito,
  • Pietro Randazzo,
  • Daniela Arosio,
  • Pierfausto Seneci,
  • Giovanni Piccoli

DOI
https://doi.org/10.3390/pharmaceutics14040862
Journal volume & issue
Vol. 14, no. 4
p. 862

Abstract

Read online

The disaccharide trehalose is a well-established autophagy inducer, but its therapeutic application is severely hampered by its low potency and poor pharmacokinetic profile. Thus, we targeted the rational design and synthesis of trehalose-based small molecules and nano objects to overcome such issues. Among several rationally designed trehalose-centered putative autophagy inducers, we coupled trehalose via suitable spacers with known self-assembly inducer squalene to yield two nanolipid-trehalose conjugates. Squalene is known for its propensity, once linked to a bioactive compound, to assemble in aqueous media in controlled conditions, internalizing its payload and forming nanoassemblies with better pharmacokinetics. We assembled squalene conjugates to produce the corresponding nanoassemblies, characterized by a hydrodynamic diameter of 188 and 184 nm and a high stability in aqueous media as demonstrated by the measured Z-potential. Moreover, the nanoassemblies were characterized for their toxicity and capability to induce autophagy in vitro.

Keywords